In a year marked by numerous market headwinds, AstraZeneca managed to beat analyst expectations with its full-year earnings. For 2024, the pharma giant’s total revenues ... in compensation last year.

The market's attention remains fixated on obesity ... Novo Nordisk (NYSE: NVO) just struck a big deal with a Chinese drugmaker, The United Laboratories International Holdings Limited, to license ...

In his March 17 op-ed, “We should stop acting as if Big Pharma is the big villain in American ... asserts, “A free-market system could and should provide a saner, more streamlined, and ...

Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...

“Despite the allure of the lucrative orphan drug market, this is not a viable sector for all pharma companies as it requires specialist capabilities,” GlobalData said. “In fact, most big ...

That means on March 19, safe, lower-cost alternatives will be removed from the market — and Big Pharma’s profits will skyrocket. When Dr. Marty Makary, President Trump’s nominee as FDA ...

With over 5 million BCC cases diagnosed annually in the U.S., Medicus Pharma targets a $2 billion share of the $15 billion North American skin cancer market ... just struck a big deal with ...